Nature
3 days ago · First published in 1869, Nature is the world’s leading multidisciplinary science journal. Nature publishes the finest peer-reviewed research that drives ground-breaking …
Research articles - Nature
2 days ago · Read the latest Research articles from Nature. We evaluated the use of chimeric antigen receptor-modified T cells targeting GD2 (GD2-CART) for H3K27M + diffuse midline …
Journal Metrics | Nature Portfolio
2023 Journal Metrics. On this page you will find a suite of citation-based metrics for Nature Portfolio journals, produced by Clarivate Analytics. Brief definitions for each of the metrics …
The human stress response - Nature Reviews Endocrinology
Jun 27, 2019 · The human stress response is an additional homeostatic mechanism that provides a better chance of survival when the body is under threat and mobilizes neural and hormonal …
Publish with Scientific Reports - Nature
Publish in Scientific Reports: multidisciplinary, open access journal, with 3.8 Impact Factor, 20 days to first decision and 135M annual downloads.
Advancing Cancer Therapy - Nature
Mar 24, 2021 · Cancer therapies have evolved considerably in recent decades, substantially improving the quality of life and survival of patients with cancer. In this issue, we launch our …
Browse Articles | Nature
Nov 6, 2024 · Browse the archive of articles on Nature. Analysis of the stellar population properties of 30 host galaxies of fast radio bursts (FRBs) suggests an abundance of FRBs in …
Online education in the post-COVID era | Nature Electronics
Jan 25, 2021 · 336 Altmetric. Metrics. The coronavirus pandemic has forced students and educators across all levels of education to rapidly adapt to online learning. The impact of this …
Breast cancer - Nature Reviews Disease Primers
Sep 23, 2019 · Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70–80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with …
Nature Cancer
Sep 10, 2024 · Nature Cancer publishes research, reviews and comment across the spectrum of the cancer field, from fundamental preclinical, to translational and clinical work.